arrow_back Back Filing freshness 10-Q Q3 FY2026 SEC EDGAR

Electromed, Inc.

ELMD
$42.40 ▲ +0.47 (+1.12%) at close
Healthcare ·Electromedical & Electrotherapeutic Apparatus ·USElectromedical & Electrotherapeutic Apparatus
64 Visible periods
32 Metrics
Peer-ranked Benchmarks
Price Chart
78
Health
Good
Bullish
auto_awesome

Analytical Summary

Electromed, Inc. shows strong fundamentals with top-quartile Return on Common Equity (%). The company's metrics support a bullish outlook for growth-oriented investors.

Market Cap $348.2M
Dividend Yield
Revenue Growth 18.4%
Op. Margin 20.3%
ROIC 5.9%
FCF / Share $0.41
Trailing P/E 114.6x
Price / Book 7.1x
FCF Yield 1.0%
Debt / Equity
info Valuation on last close. End-of-day price, Aug 7, 2026.

64-Year Financial Trajectory

Quarterly
Metric Value Trend Year over Year Percentile
Revenue Total top-line sales
$18.57M
↑ +18.4%
Net Income Profit after all expenses
$2.14M
↑ +44.9%
Operating Margin Operating profit as % of sales
20.3%
↑ +5.8% 67th
FCF / Share Free cash flow per share
$0.41
↑ +40.2%
Long-Term Debt Long-term obligations
$1.09M
↓ -1.1%
trending_up

Bullish Indicators

  • Return on Common Equity (%)Return on Common Equity (%) is in the top quartile
warning

Bearish Risks

  • No bearish risks detected.

Health Breakdown

Profitability
71
Returns
84
Cash Quality
79

bar_chart Data from SEC EDGAR XBRL filings

Synced 1 week ago 16 years · 64 quarters